Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Markowitz

Showing results (51-60 of 91) with videos related to

Pageof 10
Sort By:
Pediatrics|June 5, 2007
Laboratory values for children with newly diagnosed inflammatory bowel diseaseDavid R Mack, Christine Langton, James Markowitz, et al.
The American Journal of Gastroenterology|September 3, 2009
Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's diseaseJoel R Rosh, Trudy Lerer, James Markowitz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 25, 2006
Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's diseaseJames Markowitz, Jeffrey Hyams, David Mack, et al.
The American Journal of Surgical Pathology|September 2, 2017
Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative ColitisBrendan Boyle, Margaret H Collins, Zhu Wang, et al.
Inflammatory Bowel Diseases|January 24, 2009
Appraisal of the pediatric ulcerative colitis activity index (PUCAI)Dan Turner, Jeffrey Hyams, James Markowitz, et al.
Inflammatory Bowel Diseases|November 22, 2008
Course and treatment of perianal disease in children newly diagnosed with Crohn's diseaseDavid J Keljo, James Markowitz, Christine Langton, et al.
Inflammatory Bowel Diseases|April 27, 2021
Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative ColitisJeffrey S Hyams, Michael Brimacombe, Yael Haberman, et al.
The American Journal of Gastroenterology|January 13, 2011
Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry studyJeffrey S Hyams, Trudy Lerer, David Mack, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 26, 2015
Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's DiseaseVictoria Grossi, Trudy Lerer, Anne Griffiths, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 1, 2012
Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitisBella Zeisler, Trudy Lerer, James Markowitz, et al.
Pageof 10

Showing results (51-60 of 91) with videos related to

Sort By:
Pageof 10
Pediatrics|June 5, 2007
Laboratory values for children with newly diagnosed inflammatory bowel diseaseDavid R Mack, Christine Langton, James Markowitz, et al.
The American Journal of Gastroenterology|September 3, 2009
Retrospective Evaluation of the Safety and Effect of Adalimumab Therapy (RESEAT) in pediatric Crohn's diseaseJoel R Rosh, Trudy Lerer, James Markowitz, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 25, 2006
Corticosteroid therapy in the age of infliximab: acute and 1-year outcomes in newly diagnosed children with Crohn's diseaseJames Markowitz, Jeffrey Hyams, David Mack, et al.
The American Journal of Surgical Pathology|September 2, 2017
Histologic Correlates of Clinical and Endoscopic Severity in Children Newly Diagnosed With Ulcerative ColitisBrendan Boyle, Margaret H Collins, Zhu Wang, et al.
Inflammatory Bowel Diseases|January 24, 2009
Appraisal of the pediatric ulcerative colitis activity index (PUCAI)Dan Turner, Jeffrey Hyams, James Markowitz, et al.
Inflammatory Bowel Diseases|November 22, 2008
Course and treatment of perianal disease in children newly diagnosed with Crohn's diseaseDavid J Keljo, James Markowitz, Christine Langton, et al.
Inflammatory Bowel Diseases|April 27, 2021
Clinical and Host Biological Factors Predict Colectomy Risk in Children Newly Diagnosed With Ulcerative ColitisJeffrey S Hyams, Michael Brimacombe, Yael Haberman, et al.
The American Journal of Gastroenterology|January 13, 2011
Outcome following thiopurine use in children with ulcerative colitis: a prospective multicenter registry studyJeffrey S Hyams, Trudy Lerer, David Mack, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 26, 2015
Concomitant Use of Immunomodulators Affects the Durability of Infliximab Therapy in Children With Crohn's DiseaseVictoria Grossi, Trudy Lerer, Anne Griffiths, et al.
Journal of Pediatric Gastroenterology and Nutrition|August 1, 2012
Outcome following aminosalicylate therapy in children newly diagnosed as having ulcerative colitisBella Zeisler, Trudy Lerer, James Markowitz, et al.
Pageof 10